Analyst Ratings for Capricor Therapeutics (CAPR)
CAPR Rating Summary
CAPR Price Target Summary
- Highest: $28.00 (Cantor Fitzgerald)
- Lowest: $5.00 (B.Riley)
- Average: $16.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$16.25 (+88.1%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$16.25 (+88.1%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Piper Sandler | Edward Tenthoff | Upgrade | Overweight (Neutral) |
25.00 (N/A) |
9.59 (8.64) |
-9.91% | Details |
| 8/25/2026 | Oppenheimer | Leland Gershall | Upgrade | Outperform (Perform) |
N/A (N/A) |
6.80 (8.64) |
27.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
